Login / Signup

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.

Robin L JonesRobert G MakiShreyaskumar R PatelGeorge WangTracy A McGowanWaleed S ShalabyRoland E KnoblauchMargaret von MehrenGeorge D Demetri
Published in: Cancer (2019)
Although the majority of patients who were randomized to trabectedin received outpatient therapy, the outcomes of the current study suggested equivalent safety and efficacy in either setting.
Keyphrases
  • open label
  • double blind
  • mental health
  • palliative care
  • clinical trial
  • phase iii
  • type diabetes
  • stem cells
  • metabolic syndrome
  • bone marrow
  • cell therapy
  • replacement therapy